Departed
Alan J. Levy
Director
ISRG ·
INTUITIVE SURGICAL INC
Alan J. Levy, Ph.D., who did not stand for re-election at the Annual Meeting
Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 9701–9750 of 75496
Alan J. Levy, Ph.D., who did not stand for re-election at the Annual Meeting
following the departure of Andrew W. Murphy, who has been recruited by another company to serve as their Chief Financial Officer.
Bob Lapetina notified Immunome, Inc. (the “Company”) that he will be resigning from his positions as the Company’s Vice President, Finance, Corporate Controller, and principal accounting officer to pursue other opportunities.
Christopher S. Sotos informed Clearway Energy, Inc. (the “Company”) that, effective as of June 30, 2024 (the “Effective Date), he will move on from his position as President and Chief Executive Officer of the Company and resign from his role as a member of the Board of Directors
On April 30, 2024, Christopher S. Sotos informed Clearway Energy, Inc. (“Clearway, Inc.”), the parent company of Clearway Energy LLC (the “Company”) that, effective as of June 30, 2024 (the “Effective Date), he will move on from his position as President and Chief Executive Officer of Clearway, Inc. and the Company to pursue other opportunities.
Dr. Eugene Scherbakov will transition from his role as the Company’s Chief Executive Officer, effective as of June 5, 2024
As previously announced, William B. Rutherford, HCA Healthcare, Inc.’s (the “Company’s”) Executive Vice President, Chief Financial Officer, principal financial officer and principal accounting officer notified the Company of his intent to retire, effective May 1, 2024.
On April 25, 2024, Matthew T. Argano, the Senior Vice President and Chief Human Resources Officer of LL Flooring Holdings, Inc. (the “Company”) provided notice to the Company that he was resigning to pursue another opportunity outside of the home improvement industry.
On April 26, 2024, Timothy D. Roberts, Executive Vice President, Midstream and Chemicals of Phillips 66 (the “Company”) provided notice to the Company that he intends to retire, effective June 1, 2024.
On April 29, 2024, James G. Silk resigned as a member of the Board of Directors (the “Board”) of Beneficient (the “Company” or “Ben”) and from his role as Executive Vice President and Chief Legal Officer of the Company effective May 10, 2024.
Chris Lundell, Chief Executive Officer, and member of the Board, stepped down as Chief Executive Officer.
Mark R. Hunter has resigned from the Board of Directors, effective at the completion of the 2024 Annual Meeting of the Company’s stockholders held on April 25, 2024.
each member of the Company’s board of directors (Amy Hanson, Craig Denson, Andrew Fox, Benjamin Carson, Jr., Justin Deutsch, Gary Jacobs, Chantel Lenard and Jacky Wu) tendered his or her resignation to the Company, to be effective upon the Effective Date.
each member of the Company’s board of directors (Amy Hanson, Craig Denson, Andrew Fox, Benjamin Carson, Jr., Justin Deutsch, Gary Jacobs, Chantel Lenard and Jacky Wu) tendered his or her resignation to the Company, to be effective upon the Effective Date.
each of the Company’s named executive officers (Craig Denson, Leah Schweller, and Jim Biehl) will be separated from and will no longer be officers of the Company.
each of the Company’s named executive officers (Craig Denson, Leah Schweller, and Jim Biehl) will be separated from and will no longer be officers of the Company.
each member of the Company’s board of directors (Amy Hanson, Craig Denson, Andrew Fox, Benjamin Carson, Jr., Justin Deutsch, Gary Jacobs, Chantel Lenard and Jacky Wu) tendered his or her resignation to the Company, to be effective upon the Effective Date.
each member of the Company’s board of directors (Amy Hanson, Craig Denson, Andrew Fox, Benjamin Carson, Jr., Justin Deutsch, Gary Jacobs, Chantel Lenard and Jacky Wu) tendered his or her resignation to the Company, to be effective upon the Effective Date.
each member of the Company’s board of directors (Amy Hanson, Craig Denson, Andrew Fox, Benjamin Carson, Jr., Justin Deutsch, Gary Jacobs, Chantel Lenard and Jacky Wu) tendered his or her resignation to the Company, to be effective upon the Effective Date.
each of the Company’s named executive officers (Craig Denson, Leah Schweller, and Jim Biehl) will be separated from and will no longer be officers of the Company.
each member of the Company’s board of directors (Amy Hanson, Craig Denson, Andrew Fox, Benjamin Carson, Jr., Justin Deutsch, Gary Jacobs, Chantel Lenard and Jacky Wu) tendered his or her resignation to the Company, to be effective upon the Effective Date.
each member of the Company’s board of directors (Amy Hanson, Craig Denson, Andrew Fox, Benjamin Carson, Jr., Justin Deutsch, Gary Jacobs, Chantel Lenard and Jacky Wu) tendered his or her resignation to the Company, to be effective upon the Effective Date.
each member of the Company’s board of directors (Amy Hanson, Craig Denson, Andrew Fox, Benjamin Carson, Jr., Justin Deutsch, Gary Jacobs, Chantel Lenard and Jacky Wu) tendered his or her resignation to the Company, to be effective upon the Effective Date.
On April 29, 2024, Jeffrey Meisner resigned as a member of the board of directors (the “Board”) of The Glimpse Group, Inc. (the “Company”), effective April 29, 2024.
on April 25, 2024, B. Sonny Bal, MD, informed the board of directors of his intention to retire from his position as President and Chief Executive Officer of SINTX Technologies, Inc.
As contemplated by the Director Tenure & Resignation Policy of the Board of Directors of Linde plc, Martin H. Richenhagen retired from the Board of Directors effective April 29, 2024.
Effective immediately following the closing of the RPV Note Acquisition, Michael Fanfant and Yakov “Jack” Zubarev, directors of the Board of Directors (the “ Board ”) of the Company who were selected by RPV Ventures pursuant to the terms of the RPV Note, resigned as directors of the Company.
Effective immediately following the closing of the RPV Note Acquisition, Michael Fanfant and Yakov “Jack” Zubarev, directors of the Board of Directors (the “ Board ”) of the Company who were selected by RPV Ventures pursuant to the terms of the RPV Note, resigned as directors of the Company.
On April 24, 2024, Linda Van Etten, EQT Exeter Real Estate Income Trust, Inc.'s (the "Company") Controller and Treasurer, provided notice of her intent to resign from the Company. Ms. Van Etten’s resignation is effective May 17, 2024.
succeeds S.P. (Simon) Younger, who has been appointed Lead Country Manager and General Manager Australia Conventional, ExxonMobil Upstream.
Jane Buchan retired from the Globe Life Inc. Board of Directors at the Annual Meeting of Shareholders on April 25, 2024.
the Company entered into a consulting agreement with Mr. Harshman (the “Harshman Consulting Agreement”), effective June 11, 2024, and ending on the one-year anniversary thereof, subject to any extension by mutual agreement between the parties.
On April 25, 2024, Cecil W. “Chip” Knight, Jr., Executive Vice President, Chief Banking Officer of Hancock Whitney Corporation (the “Company”) announced his departure from the Company, effective July 5, 2024, in order to pursue other interests.
Mr. Schmidt will succeed Jerald K. Dittmer who has announced his resignation from the position of Chief Executive Officer effective June 30, 2024, and retirement from the Company on December 31, 2024.
Effective April 25, 2024, Tian “Todd” Zhang resigned as a member of the board of directors (the “Board”) of LM Funding America, Inc. (the “Company”).
Eva M. Kalawski and Mary Ann Sigler were not nominated for re-election to the Board of Directors of Ryerson Holding Corporation (“Ryerson” or the “Company”), and effective as of April 25, 2024, each ceased to serve as directors of the Company.
Eva M. Kalawski and Mary Ann Sigler were not nominated for re-election to the Board of Directors of Ryerson Holding Corporation (“Ryerson” or the “Company”), and effective as of April 25, 2024, each ceased to serve as directors of the Company.
Mr. Hulett resigned as President and Chief Executive Officer, and also as a director, of the Company effective April 29, 2024
On April 24, 2024, Lonnel Coats notified us of his retirement as our chief executive officer (in which capacity, Mr. Coats functions as our principal executive officer) and as a member of our board of directors, in each case effective July 7, 2024.
On April 24, 2024, Lonnel Coats notified us of his retirement as our chief executive officer (in which capacity, Mr. Coats functions as our principal executive officer) and as a member of our board of directors, in each case effective July 7, 2024.
Tom McMillin delivered notice of his resignation from the Board of Directors (the “Board”) of WideOpenWest, Inc. (the “Company”) effective May 17, 2024.
On April 25, 2024, Jon Hendry, the Executive Vice President and Chief Technology Officer for Alerus Financial Corporation (the “Company”), notified the Company of his intention to retire from his position on December 31, 2024.
On April 25, 2024, Gérard Ber, Ph.D., notified Y-mAbs Therapeutics, Inc. (the “Company”) that he would be resigning from the Board of Directors of the Company, with such resignation to be effective on June 10, 2024, the day before the date set for the Company’s 2024 annual meeting of stockholders.
Resignation of Chief Financial Officer Effective as of the Appointment Date, the Company’s current Chief Financial Off
On April 23, 2024, Melinda Weston, Chief Accounting Officer of Terreno Realty Corporation (the “Company”), notified the Company that she would be resigning, effective June 30, 2024.
from Christopher Melton pursuant to which he resigned as a member of the Board, effective immediately.
three current members of the Company’s Board of Directors, John Held, Thomas Lardieri, and Alicia Morga, will not stand for re-election at the Company’s Annual General and Special Meeting scheduled for June 13, 2024.
three current members of the Company’s Board of Directors, John Held, Thomas Lardieri, and Alicia Morga, will not stand for re-election at the Company’s Annual General and Special Meeting scheduled for June 13, 2024.
three current members of the Company’s Board of Directors, John Held, Thomas Lardieri, and Alicia Morga, will not stand for re-election at the Company’s Annual General and Special Meeting scheduled for June 13, 2024.
On April 26, 2024, each of Andrew B. Cohen, Lisa R. Jacobs, Harry D. Madonna and Harris Wildstein resigned as a director of the Company, which resignations have become effective.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.